Journal of Medicinal Chemistry · 2007 · 13 citations · 5 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryInflammationRheumatologyAnti-inflammatory PharmacologyCytokine BiologyInflammatory ArthritisInflammatory SignalingRheumatoid ArthritisSteroid Hormone SignalingAnti-inflammatory Drug DiscoveryAnti-inflammatory Drug MechanismsAnti-inflammatory MechanismsEstrogen Receptor SignalingNonsteroidal Anti-inflammatory Drug PharmacologyProinflammatory MediatorsRheumatoid Arthritis PharmacotherapyRheumatoid Arthritis Therapy
Pathway selective ligands of the estrogen receptor inhibit transcriptional activation of proinflammatory genes mediated by NF-kappaB. Substituted 2-cyanopropanoic acid derivatives were developed leading to the discovery of WAY-204688, an orally active, pathway selective, estrogen receptor dependent anti-inflammatory agent. This propanamide was shown to be orally active in preclinical models of inflammatory diseases, such as rheumatoid arthritis, without the proliferative effect associated with traditional estrogens.
5
NF-κB functions as a tumour promoter in inflammation-associated cancer
Eli Pikarsky, Rinnat M. Porat, Ilan Stein et al. · Nature · 2004 · 2.4K citations
Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice
Lina Kassar-Duchossoy, Barbara Gayraud-Morel, Danielle Gomès et al. · Nature · 2004 · 665 citations
Robert J. Steffan, Edward Matelan, Mark A. Ashwell et al. · Journal of Medicinal Chemistry · 2004 · 70 citations · Full text